Ewelina K. Mamcarz, MD
Ewelina K. Mamcarz, MD

Ewelina K. Mamcarz, MD

Associate Member, St. Jude Faculty

Departments

Education

MD – Medical University of Silesia (Slaska Akademia Medyczna), Katowice, Poland
Residency – Marshfield Clinic-Saint Joseph’s Children’s Hospital of Marshfield, Marshfield, Wisconsin
Fellowship – Children’s National Medical Center, Washington, DC / National Institutes of Health, NHLBI, Hematology Branch, Bethesda, Maryland
Fellowship – St. Jude Children’s Research Hospital, Memphis, Tennessee

Research Interests

  • Transplantation for patients with non-malignant diseases
  • HLA alloimmunization and desensitization in hematopoietic stem cell transplant recipients

Contact Information

Ewelina K. Mamcarz, MD Bone Marrow Transplantation & Cellular Therapy MS 1130, Room I3304 St. Jude Children's Research Hospital 262 Danny Thomas Place Memphis, TN 38105-3678

St. Jude Faculty List

Related Topics

News Releases

Clinical Trials

Selected Publications

Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, Ma Z, Condori J, Dowdy J, Triplett B, Li C, Maron G, Aldave CJ, Church JA, Dokmeci E, Love JT, da Matta Ain AC, van der Watt H, Tang X, Janssen W, Ryu BY, De Ravin SS, Weiss MJ, Youngblood B, Long-Boyle JR, Gottschalk S, Meagher MM, Malech HL, Puck JM, Cowan MJ, Sorrentino BP. Lentiviral gene therapy with low dose busulfan for infants with X-SCID. N Engl J Med 380(16):1525-1534, 2019.

Talleur AC, Triplett BM, Federico S, Mamcarz E, Janssen W, Wu J, Shook D, Leung W, Furman WL. Consolidation therapy for newly diagnosed pediatric patients with high-risk neuroblastoma using busulfan/melphalan, autologous hematopoietic cell transplantation, ant_GD2 antibody, granulocyte-macrophage colony-stimulating factor, interleukin-2, and haploidentical Natural Killer Cells. Biol Blood Marrow Transplant Nov; 23(11):1910-1917, 2017.

Triplett B, Muller B, Kang G, Li Y, Cross S, Moen J, Cunningham L, Janssen W, Mamcarz E, Shook D, Srinivasan A, Choi J, Hayden Randall, Leung W. Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T cell recovery compared to CD3-targeted T-cell depletion. Transplant Infect Dis Aug:20e12823, 2017.

Helton K, Maron G, Mamcarz E, Leventaki V, Patay Z, Patay Z, Sadighi Z. Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis. Bone Marrow Transplant Jun:51:1533-1536, 2016.

Fasano R, Mamcarz E, Adams S, Donohue Jerussi T, Sugimoto K, Tian X, Flegel W, Childs R. HLA antibody persistence and de novo production of donor origin following reduced intensity allogeneic hematopoietic stem cell transplantation. Br J Hematol 166(3):425-34, 2014.

Zarzecki M, Chudek J, Kukla M, Kopec P, Mamcarz E, Wnuk Z, Kokot F, Wiecek A. Prevalence of anemia, calcium-phosphorus abnormalities and metabolic acidosis in different stages of chronic renal failure. Pol Arch Med Wew 112:1211-1219, 2004.

Kukla M, Zarzecki M, Szotowska M, Kopec P, Mamcarz E, Wnuk Z, Wiencek R, Chudek J, Kokot F, Wiecek A. Arterial hypertension.relationship between peripheral white blood count and arterial blood pressure in patients with essential hypertension. Via Medica 7(4):253-261, 2003.

Last update: July 2019

Close
Close